Literature DB >> 20711930

Genetic variation at a metallothionein 2A promoter single-nucleotide polymorphism in white and black females in Midwestern United States.

Jane A McElroy1, Elizabeth C Bryda, Stephanie D McKay, Robert D Schnabel, Jeremy F Taylor.   

Abstract

Genetic variation leading to differences in expression and regulation of metallothionein proteins may contribute to observed differences among individuals in terms of cadmium (Cd) uptake and metabolism. The aim of this study was to determine the frequency of the A and G alleles at rs28366003, which lies in the 5' promoter region of MT2A, in White and Black females in the Midwestern United States. One-milliliter saliva samples were collected from 298 White or Black adult female volunteers, and DNA was isolated from each sample using Oragene*DNA kits. Allele-specific PCR with gel visualization of amplification products was used to genotype SNP rs28366003. Of the 291 participants (Black = 142; White = 149), the average yield of DNA extracted from the saliva samples was 23.4 microg. The samples, quantitated on a spectrophotometer, achieved an average 260/280 optical density reading of 1.61. The frequency of the G allele was 1.1% for Blacks and 6.4% for Whites. Data demonstrated that the G allele is not common in both the Midwestern U.S. Black and White female population and is less frequent than that reported for an Asian population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20711930     DOI: 10.1080/15287394.2010.485067

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  6 in total

1.  Genetic polymorphism of metallothionein 2A and risk of laryngeal cancer in a Polish population.

Authors:  Katarzyna Starska; Anna Krześlak; Ewa Forma; Jurek Olszewski; Iwona Lewy-Trenda; Ewa Osuch-Wójcikiewicz; Magdalena Bryś
Journal:  Med Oncol       Date:  2014-06-22       Impact factor: 3.064

2.  Genetic variation in metallothionein and metal-regulatory transcription factor 1 in relation to urinary cadmium, copper, and zinc.

Authors:  Scott V Adams; Brian Barrick; Emily P Christopher; Martin M Shafer; Karen W Makar; Xiaoling Song; Johanna W Lampe; Hugo Vilchis; April Ulery; Polly A Newcomb
Journal:  Toxicol Appl Pharmacol       Date:  2015-10-31       Impact factor: 4.219

3.  Metallothionein 2A genetic polymorphisms and risk of ductal breast cancer.

Authors:  Anna Krześlak; Ewa Forma; Paweł Jóźwiak; Agnieszka Szymczyk; Beata Smolarz; Hanna Romanowicz-Makowska; Waldemar Różański; Magdalena Bryś
Journal:  Clin Exp Med       Date:  2012-10-06       Impact factor: 3.984

4.  Metallothionein 2A core promoter region genetic polymorphism and its impact on the risk, tumor behavior, and recurrences of sinonasal inverted papilloma (Schneiderian papilloma).

Authors:  Katarzyna Starska; Magdalena Bryś; Ewa Forma; Jurek Olszewski; Piotr Pietkiewicz; Iwona Lewy-Trenda; Olga Stasikowska-Kanicka; Marian Danilewicz; Anna Krześlak
Journal:  Tumour Biol       Date:  2015-06-03

Review 5.  Metallothionein 2A gene polymorphisms in relation to diseases and trace element levels in humans.

Authors:  Ankica Sekovanić; Jasna Jurasović; Martina Piasek
Journal:  Arh Hig Rada Toksikol       Date:  2020-03-01       Impact factor: 1.948

6.  Metallothionein MT2A A-5G Polymorphism as a Risk Factor for Chronic Kidney Disease and Diabetes: Cross-Sectional and Cohort Studies.

Authors:  Yuta Hattori; Mariko Naito; Masahiko Satoh; Masahiro Nakatochi; Hisao Naito; Masashi Kato; Sahoko Takagi; Takashi Matsunaga; Toshio Seiki; Tae Sasakabe; Shino Suma; Sayo Kawai; Rieko Okada; Asahi Hishida; Nobuyuki Hamajima; Kenji Wakai
Journal:  Toxicol Sci       Date:  2016-04-27       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.